Prefilled Syringes Market, By Material, By Drug Type, By Design, By Product Type, By Usability, By Manufacturing Method, By End User, By Geography

Description

Prefilled Syringes Market is estimated to be valued at USD 7.18 Bn in 2025 and is expected to reach USD 10.51 Bn by 2032, growing at a compound annual growth rate (CAGR) of 5.6% from 2025 to 2032.

Report Coverage		Report Details
Base Year:	2024	Market Size in 2025:	USD 7.18 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	5.60%	2032 Value Projection:	USD 10.51 Bn

Pre-filled syringes are single-use syringes that are pre-loaded with the medication that will be injected. It is a single dose of medicine with a needle attached by the manufacturer. As these syringes are prefilled, nurses or patients do not need to prepare the medication and pull it into the needle; instead, the appropriate dosage is already present in the barrel and is ready for speedy injection. Moreover, prefilled syringes are safer to use since they are highly accurate. Some cartridges of prefilled syringes are made to fit into self-aspirating syringes, which penetrate the skin and provide drugs without the need to press a plunger. This guarantees that doses are supplied smoothly and that injections reach the proper depth.

Market Dynamics

Increasing incidence of chronic diseases which leads to driving the demand of prefilled syringes as its treatment is expected to fuel the market growth over the forecast period. For instance, according to the Centers for Disease Control and Prevention data on chronic diseases updated in July 2022, around six in ten adults in the U.S. were affected by a type of chronic disease, and over four in ten adults were affected by two or more chronic diseases. Cancer is the most common chronic disease affecting people worldwide. For instance, according to the GLOBOCAN 2020 report, the total number of people in the world affected by cancer in 2020 accounted for around 19,292,789 cases. The number is estimated to rise to 28,887,940 cases by 2040. Several types of cancer are treated with the help of novel drugs and biologics, which is expected to increase the demand for prefilled syringes over forecast period 2025-2032. Thus, the rising cancer cases across the world is expected to boost the growth of the prefilled syringes market over the forecast period.

The increasing approvals from various regulatory agencies by market players to expand product portfolio is expected to drive the market growth over the forecast period. For instance, in December 2022, Alembic Pharmaceuticals Limited, a multinational pharmaceutical company, announced that it had received final approval from the U.S. Food & Drug Administration for its Abbreviated New Drug Application (ANDA), Fulvestrant Injection, 250 mg/5 mL (50 mg/mL) per Single-Dose Prefilled Syringe. Fulvestrant Injection is an estrogen receptor antagonist indicated for the treatment of breast cancer.

Key features of the study

This report provides in-depth analysis of the global prefilled syringes market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global prefilled syringes market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this study include Gerresheimer AG, Becton Dickinson and Company, West Pharmaceutical Services, Inc., Terumo Corporation, Nipro Europe Group Companies, B. Braun SE, Sanofi, GSK plc., Pfizer Inc., Bayer AG, Polymedicure, Amsino International, Inc., Leeford Healthcare Limited, Torrent Pharmaceuticals Ltd., Regeneron Pharmaceuticals Inc., Ypsomed AG, SOL-Millennium, and Stevanato Group S.p.A.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global prefilled syringes market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global prefilled syringes market

Market Segmentation

Global Prefilled Syringes Market, By Material
- Glass
- Plastic/Polymer
Global Prefilled Syringes Market, By Drug Type
- Biologics
- Monoclonal Antibodies
- Blood Products
- Others (Erythropoietin, Therapeutic proteins, among others)
- Vaccines
- Conjugated Vaccines
- Live Attenuated Vaccines
- Recombinant Vaccines
- Others (Virus-like particles (VLPs), Viral vector vaccines)
- Insulin
- Anticoagulants
- Flush Saline Syringes
- Others
Global Prefilled Syringes Market, By Design
- Single-chamber
- Dual-chamber
- Multi-chambered
Global Prefilled Syringes Market, By Product Type
- Staked in-needle pre-filled syringes
- Needle-free pre-filled syringes
Global Prefilled Syringes Market, By Usability
- Disposable
- Reusable
Global Prefilled Syringes Market, By Manufacturing Method
- Captive
- Merchant
Global Prefilled Syringes Market, By End User
- Hospital
- Clinics
- Ambulatory Surgical Centers
- Others
Global Prefilled Syringes Market, By Region
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC
- Israel
- Rest of Middle East
- Africa
- South Africa
- Central Africa
- North Africa
Company Profiles
- Gerresheimer AG
- Becton, Dickinson and Company
- West Pharmaceutical Services, Inc.
- Terumo Corporation
- Nipro Europe Group Companies
- B. Braun SE
- Sanofi
- GSK plc.
- Pfizer Inc.
- Bayer AG
- Polymedicure
- Amsino International, Inc.
- Leeford Healthcare Limited
- Torrent Pharmaceuticals Ltd.
- Regeneron Pharmaceuticals Inc.
- Ypsomed AG
- SOL-Millennium
- Stevanato Group S.p.A.

Product Code: CMI162

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Material
- Market Snapshot, By Drug Type
- Market Snapshot, By Design
- Market Snapshot, By Product Type
- Market Snapshot, By Usability
- Market Snapshot, By Manufacturing Method
- Market Snapshot, By End User
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Attractiveness Analysis
- Market Opportunities
Product Launches
Merger, Acquisition, Collaborations
Regulatory Guideline and Compliances
Key Developments
PEST Analysis
Technology Landscape
Service Cost Analysis

4. Global Prefilled Syringes Market, By Material, 2025-2032, (US$ Billion)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Glass
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2025-2032, (US$ Billion)
Plastic/Polymer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2025-2032, (US$ Billion)

5. Global Prefilled Syringes Market, By Drug Type, 2025-2032, (US$ Billion)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Biologics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2025-2032, (US$ Billion)
  - Monoclonal Antibodies
  - Blood Products
  - Others (Erythropoietin, Therapeutic proteins, among others)
Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2025-2032, (US$ Billion)
  - Conjugated Vaccines
  - Live Attenuated Vaccines
  - Recombinant Vaccines
  - Others (Virus-like particles (VLPs), Viral vector vaccines)
Insulin
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2025-2032, (US$ Billion)
Anticoagulants
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2025-2032, (US$ Billion)
Flush Saline Syringes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2025-2032, (US$ Billion)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2025-2032, (US$ Billion)

6. Global Prefilled Syringes Market, By Design, 2025 - 2032, (US$ Billion)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Single-chamber
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2025-2032, (US$ Billion)
Dual-chamber
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2025-2032, (US$ Billion)
Multi-chambered
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2025-2032, (US$ Billion)

7. Global Prefilled Syringes Market, By Product Type, 2025 - 2032, (US$ Billion)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Staked in-needle pre-filled syringes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2025-2032, (US$ Billion)
Needle-free pre-filled syringes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2025-2032, (US$ Billion)

8. Global Prefilled Syringes Market, By Usability, 2025 - 2032, (US$ Billion)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Disposable
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2025-2032, (US$ Billion)
Reusable
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2025-2032, (US$ Billion)

9. Global Prefilled Syringes Market, By Manufacturing Method, 2025 - 2032, (US$ Billion)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Captive
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2025-2032, (US$ Billion)
Merchant
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2025-2032, (US$ Billion)

10. Global Prefilled Syringes Market, By End User, 2025 - 2032, (US$ Billion

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segments Trends
Hospital
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2025-2032, (US$ Billion)
Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2025-2032, (US$ Billion)
Ambulatory Surgical Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2025-2032, (US$ Billion)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2025-2032, (US$ Billion)

11. Global Prefilled Syringes Market, By Region, 2025 - 2032, (US$ Billion)

Introduction
- Market Share Analysis, By Region, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Regions, 2021-2032
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Material, 2025 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2025 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Design, 2025 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2025 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Usability, 2025 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Manufacturing Method, 2025 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2025 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2025 - 2032, (US$ Billion)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Material, 2025 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2025 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Design, 2025 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2025 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Usability, 2025 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Manufacturing Method, 2025 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2025 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2025 - 2032, (US$ Billion)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Material, 2025 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2025 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Design, 2025 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2025 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Usability, 2025 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Manufacturing Method, 2025 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2025 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2025 - 2032, (US$ Billion)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Material, 2025 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2025 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Design, 2025 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2025 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Usability, 2025 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Manufacturing Method, 2025 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2025 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2025 - 2032, (US$ Billion)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Material, 2025 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2025 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Design, 2025 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2025 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Usability, 2025 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Manufacturing Method, 2025 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2025 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2025 - 2032, (US$ Billion)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Material, 2025 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2025 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Design, 2025 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2025 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Usability, 2025 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Manufacturing Method, 2025 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2025 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2025 - 2032, (US$ Billion)
  - North Africa
  - Central Africa
  - South Africa

12. Competitive Landscape

Gerresheimer AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Becton, Dickinson and Company
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
West Pharmaceutical Services, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Terumo Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Nipro Europe Group Companies
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
B.Braun SE
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
GSK plc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Pfizer Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Bayer AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Polymedicure
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Amsino International, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Leeford Healthcare Limited
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Torrent Pharmaceuticals Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Regeneron Pharmaceuticals Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Ypsomed AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
SOL-Millennium
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Stevanato Group S.p.A.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies

13. Section

Research Methodology
About Us